Sarana Meditama Metropolitan (JK:SAME) — Market Cap & Net Worth
Market Cap & Net Worth: Sarana Meditama Metropolitan (SAME)
Sarana Meditama Metropolitan (JK:SAME) has a market capitalization of $297.71 Million (Rp5.08 Trillion) as of August 1, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #14644 globally and #174 in its home market, demonstrating a -0.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sarana Meditama Metropolitan's stock price Rp296.00 by its total outstanding shares 17164632545 (17.16 Billion). See SAME capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
Sarana Meditama Metropolitan Market Cap History: 2015 to 2026
Sarana Meditama Metropolitan's market capitalization history from 2015 to 2026. Data shows change from $522.20 Million to $297.71 Million (-4.60% CAGR).
Index Memberships
Sarana Meditama Metropolitan is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$486.30 Billion | 0.06% | #171 of 864 |
Weight: Sarana Meditama Metropolitan's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sarana Meditama Metropolitan Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sarana Meditama Metropolitan's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Sarana Meditama Metropolitan's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Sarana Meditama Metropolitan's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $558.59 Million | $635.02 Billion | $14.80 Billion | 0.00x | 0.04x |
| 2017 | $571.60 Million | $775.57 Billion | $72.01 Billion | 0.00x | 0.01x |
| 2018 | $563.24 Million | $952.08 Billion | $58.88 Billion | 0.00x | 0.01x |
| 2019 | $251.44 Million | $529.32 Billion | -$114.39 Billion | 0.00x | N/A |
| 2020 | $293.69 Million | $507.62 Billion | -$449.47 Billion | 0.00x | N/A |
| 2021 | $372.14 Million | $1.27 Trillion | $144.17 Billion | 0.00x | 0.00x |
| 2022 | $301.73 Million | $1.39 Trillion | $9.58 Billion | 0.00x | 0.03x |
| 2023 | $315.81 Million | $1.53 Trillion | $12.25 Billion | 0.00x | 0.03x |
| 2024 | $265.53 Million | $1.71 Trillion | $11.85 Billion | 0.00x | 0.02x |
| 2025 | $364.09 Million | $1.86 Trillion | $30.08 Billion | 0.00x | 0.01x |
Competitor Companies of SAME by Market Capitalization
Companies near Sarana Meditama Metropolitan in the global market cap rankings as of August 1, 2026.
Key companies related to Sarana Meditama Metropolitan by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #324 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #902 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1346 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #324 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $395.79 |
| #902 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.88 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1346 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
Sarana Meditama Metropolitan Historical Marketcap From 2015 to 2026
Between 2015 and today, Sarana Meditama Metropolitan's market cap moved from $522.20 Million to $ 297.71 Million, with a yearly change of -4.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp297.71 Million | -18.23% |
| 2025 | Rp364.09 Million | +37.12% |
| 2024 | Rp265.53 Million | -15.92% |
| 2023 | Rp315.81 Million | +4.67% |
| 2022 | Rp301.73 Million | -18.92% |
| 2021 | Rp372.14 Million | +26.71% |
| 2020 | Rp293.69 Million | +16.80% |
| 2019 | Rp251.44 Million | -55.36% |
| 2018 | Rp563.24 Million | -1.46% |
| 2017 | Rp571.60 Million | +2.33% |
| 2016 | Rp558.59 Million | +6.97% |
| 2015 | Rp522.20 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 31st, 2026 the market cap of Sarana Meditama Metropolitan was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $297.71 Million USD |
| MoneyControl | $297.71 Million USD |
| MarketWatch | $297.71 Million USD |
| marketcap.company | $297.71 Million USD |
| Reuters | $297.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sarana Meditama Metropolitan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Ma… Read more